Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling

被引：598

作者：

Teijaro, John R. ^{[1
]}

Cherie Ng ^{[1
]}

Lee, Andrew M. ^{[1
]}

Sullivan, Brian M. ^{[1
]}

Sheehan, Kathleen C. F. ^{[2
]}

Welch, Megan ^{[1
]}

Schreiber, Robert D. ^{[2
]}

de la Torre, Juan Carlos ^{[1
]}

Oldstone, Michael B. A. ^{[1
]}

机构：

[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA

[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA

来源：

SCIENCE | 2013年 / 340卷 / 6129期

关键词：

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VIRAL PERSISTENCE; DENDRITIC CELLS; IMMUNE ACTIVATION; GENOMIC ANALYSIS; T-CELLS; IMMUNOSUPPRESSION; MICE; VIVO; GLYCOPROTEIN;

D O I：

10.1126/science.1235214

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.

引用

页码：207 / 211

页数：6

共 36 条

[1] SELECTION OF GENETIC-VARIANTS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN SPLEENS OF PERSISTENTLY INFECTED MICE - ROLE IN SUPPRESSION OF CYTO-TOXIC LYMPHOCYTE-T RESPONSE AND VIRAL PERSISTENCE [J].

AHMED, R ;

SALMI, A ;

BUTLER, LD ;

CHILLER, JM ;

OLDSTONE, MBA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :521-540

[2] Immune activation and inflammation in HIV-I infection: causes and consequences [J].

Appay, V. ;

Sauce, D. .

JOURNAL OF PATHOLOGY, 2008, 214 (02) :231-241

[3] Restoring function in exhausted CD8 T cells during chronic viral infection [J].

Barber, DL ;

Wherry, EJ ;

Masopust, D ;

Zhu, BG ;

Allison, JP ;

Sharpe, AH ;

Freeman, GJ ;

Ahmed, R .

NATURE, 2006, 439 (7077) :682-687

[4] Lymphotoxin-β-deficient mice show defective antiviral immunity [J].

Berger, DP ;

Naniche, D ;

Crowley, MT ;

Koni, PA ;

Flavell, RA ;

Oldstone, MBA .

VIROLOGY, 1999, 260 (01) :136-147

[5] Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression [J].

Bergthaler, Andreas ;

Flatz, Lukas ;

Hegazy, Ahmed N. ;

Johnson, Susan ;

Horvath, Edit ;

Loehning, Max ;

Pinschewer, Daniel D. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (50) :21641-21646

[6] Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys [J].

Bosinger, Steven E. ;

Li, Qingsheng ;

Gordon, Shari N. ;

Klatt, Nichole R. ;

Duan, Lijie ;

Xu, Luoling ;

Francella, Nicholas ;

Sidahmed, Abubaker ;

Smith, Anthony J. ;

Cramer, Elizabeth M. ;

Zeng, Ming ;

Masopust, David ;

Carlis, John V. ;

Ran, Longsi ;

Vanderford, Thomas H. ;

Paiardini, Mirko ;

Isett, R. Benjamin ;

Baldwin, Don A. ;

Else, James G. ;

Staprans, Silvija I. ;

Silvestri, Guido ;

Haase, Ashley T. ;

Kelvin, David J. .

JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (12) :3556-3572

[7] Interleukin-10 determines viral clearance or persistence in vivo [J].

Brooks, David G. ;

Trifilo, Matthew J. ;

Edelmann, Kurt H. ;

Teyton, Luc ;

McGavern, Dorian B. ;

Oldstone, Michael B. A. .

NATURE MEDICINE, 2006, 12 (11) :1301-1309

[8] Innate Immune Activation in Primary HIV-1 Infection [J].

Chang, J. Judy ;

Altfeld, Marcus .

JOURNAL OF INFECTIOUS DISEASES, 2010, 202 :S297-S301

[9] HIV-Associated Immune Activation: From Bench to Bedside [J].

d'Ettorre, Gabriella ;

Paiardini, Mirko ;

Ceccarelli, Giancarlo ;

Silvestri, Guido ;

Vullo, Vincenzo .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (04) :355-364

[10] Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy [J].

Deeks, Steven G. ;

Walker, Bruce D. .

IMMUNITY, 2007, 27 (03) :406-416

← 1 2 3 4 →